Atlas Antibodies Launches AtlasPlex IHC Kit: Multiplexing Made Simple
Stockholm, Sweden – September 2025
Atlas Antibodies proudly announces the launch of AtlasPlex, a complete and customizable multiplex immunohistochemistry (mIHC-IF) solution for FFPE and fresh-frozen tissue.
“AtlasPlex marks a significant milestone in Atlas Antibodies’ innovation journey with a strong dedication to preserving and advancing the legacy of the Human Protein Atlas. It’s a testament to what focused innovation and strategic partnerships can achieve”, says Ingela Hofverberg, Business Unit CEO.
AtlasPlex enables researchers to detect up to five biomarkers in aday, using pre-biotinylated antibodies, optimized tyramide signal amplification (TSA), and a selection of over 12,000 validated antibodies from the Human Protein Atlas.
“AtlasPlex is a direct response to the bottlenecks researchers face in tissue-based multiplexing. We’ve removed the species puzzle, simplified the workflow, and made multiplex experiments accessible to more labs”, says Emma Ryan Lind, Head of Marketing and Product .
Key Highlights of the AtlasPlex IHC Multiplex Kit
- 3-plex and 5-plex kits with all components included
- Species-independent detection - no secondary antibodies required
- Single-day protocol with permanent signal deposition
- Custom panel design across the human proteome
- Compatible with standard fluorescence microscopy
AtlasPlex is ideal for applications in cancer research, neuroscience, and translational medicine, offering unmatched flexibility and sensitivity for low-abundance targets.